ArticleFrontiers in immunology2025

Efficacy of Tislelizumab plus Lenvatinib in hepatocellular carcinoma after curative hepatectomy: a real-world study.

Kai Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.